StockData
Psyence Biomedical Ltd. logo

Psyence Biomedical Ltd. (PBM) stock

PBMNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBMWW
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 22, 2026Score 0/30
$4.12−0.10 (-2.37%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Psyence Biomedical total assets

Total assets on the balance sheet at the end of each period.

Psyence Biomedical's total assets was $17.57M at Mar 31, 2026. For fiscal 2026 it was $17.57M, up 140.1% from the year before. The highest annual figure on record is $17.57M in fiscal 2026.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026$17.57M+140.1%
FY2025Mar 31, 2025$7.32M+546.2%
FY2024Mar 31, 2024$1.13M-28.8%
FY2023Mar 31, 2023$1.59M-13.1%
FY2022Mar 31, 2022$1.83M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026$17.57M+1451.7%
Q2 FY2026CQ3 2025Sep 30, 2025$12.81M+705.5%
Q4 FY2025CQ1 2025Mar 31, 2025$7.32M+299.7%
Q2 FY2025CQ3 2024Sep 30, 2024$2.25M–
Q4 FY2024CQ1 2024Mar 31, 2024$1.13M–
Q4 FY2023CQ1 2023Mar 31, 2023$1.59M–
Q4 FY2022CQ1 2022Mar 31, 2022$1.83M–

More Psyence Biomedical figures

See a number that looks wrong?